- Home
- ENLV vs MCR Comparison
ENLV vs MCR Comparison
Compare ENLV & MCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ENLV | MCR |
|---|---|---|
| Founded | 2005 | 1989 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 258.7M | 246.2M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | ENLV | MCR |
|---|---|---|
| Price | $0.82 | $6.08 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 756.6K | 103.4K |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.52% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.38 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $16.03 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.66 | $5.84 |
| 52 Week High | $2.10 | $6.57 |
Technical Indicators
Market Signals| Indicator | ENLV | MCR |
|---|---|---|
| Relative Strength Index (RSI) | 37.33 | 52.09 |
| Support Level | $0.81 | $6.00 |
| Resistance Level | $1.19 | $6.10 |
| Average True Range (ATR) | 0.11 | 0.09 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 13.06 | 83.93 |
Price Performance
Historical ComparisonAbout ENLV Enlivex Therapeutics Ltd.
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests the assets in Debt Instruments, Corporate Bonds, U.S. Government Securities, Foreign Government Securities, Securitized Instruments, Derivatives, Principal Risks, Debt Management Risk, Investment Selection Risk, Interest Rate Risk, Credit Risk, Foreign Risks, Emerging Markets Risk, Currency Risk, Leveraging Risk, Operational and Cybersecurity Risk, Active and Frequent Trading, and etc of different market countries.